ACADIA Pharmaceuticals Inc (ACAD)
17.07
-0.12
(-0.70%)
USD |
NASDAQ |
Apr 18, 16:00
17.08
0.00 (0.00%)
Pre-Market: 20:00
ACADIA Pharmaceuticals Total Assets (Quarterly): 748.96M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 748.96M |
| September 30, 2023 | 632.54M |
| June 30, 2023 | 642.77M |
| March 31, 2023 | 655.30M |
| December 31, 2022 | 587.81M |
| September 30, 2022 | 602.49M |
| June 30, 2022 | 612.77M |
| March 31, 2022 | 624.25M |
| December 31, 2021 | 700.12M |
| September 30, 2021 | 717.67M |
| June 30, 2021 | 724.43M |
| March 31, 2021 | 755.17M |
| December 31, 2020 | 782.62M |
| September 30, 2020 | 795.66M |
| June 30, 2020 | 759.65M |
| March 31, 2020 | 747.45M |
| December 31, 2019 | 783.18M |
| September 30, 2019 | 765.59M |
| June 30, 2019 | 460.88M |
| March 31, 2019 | 501.10M |
| December 31, 2018 | 540.20M |
| September 30, 2018 | 266.46M |
| June 30, 2018 | 314.96M |
| March 31, 2018 | 351.04M |
| December 31, 2017 | 384.51M |
| Date | Value |
|---|---|
| September 30, 2017 | 413.71M |
| June 30, 2017 | 456.32M |
| March 31, 2017 | 503.01M |
| December 31, 2016 | 561.15M |
| September 30, 2016 | 617.38M |
| June 30, 2016 | 438.03M |
| March 31, 2016 | 466.59M |
| December 31, 2015 | 221.90M |
| September 30, 2015 | 245.32M |
| June 30, 2015 | 275.54M |
| March 31, 2015 | 301.96M |
| December 31, 2014 | 325.46M |
| September 30, 2014 | 341.76M |
| June 30, 2014 | 359.46M |
| March 31, 2014 | 373.51M |
| December 31, 2013 | 189.12M |
| September 30, 2013 | 199.28M |
| June 30, 2013 | 206.91M |
| March 31, 2013 | 103.02M |
| December 31, 2012 | 108.59M |
| September 30, 2012 | 23.75M |
| June 30, 2012 | 21.87M |
| March 31, 2012 | 26.52M |
| December 31, 2011 | 32.11M |
| September 30, 2011 | 37.02M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
460.88M
Minimum
Jun 2019
795.66M
Maximum
Sep 2020
689.44M
Average
717.67M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 154.46M |
| Amylyx Pharmaceuticals Inc | 517.45M |
| Regulus Therapeutics Inc | 30.75M |
| Minerva Neurosciences Inc | 56.90M |
| Viking Therapeutics Inc | 368.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 317.20M |
| Shareholders Equity (Quarterly) | 431.76M |
| Current Ratio | 2.423 |